Understanding and overcoming chemoresistance in ovarian cancer: Emerging role of the endothelin axis

Current Oncology

Volumn 19, Issue 1, 2012, Pages 36-38

  Bagnato, A ^a   Rosano L ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Chemoresistance; Endothelin; Epithelial to mesenchymal transition; Ovarian carcinoma; Snail

Indexed keywords

ANTINEOPLASTIC AGENT; ENDOTHELIN; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; PLATINUM COMPLEX; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; ZIBOTENTAN;

ARTICLE; AUTOCRINE EFFECT; CANCER INVASION; CANCER RESISTANCE; CANCER STEM CELL; DRUG TARGETING; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; OVARY CANCER; PROTEIN EXPRESSION;

EID: 84856900563     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: 10.3747/co.19.895     Document Type: Article

References (14)

1. Bast RC Jr, Hennessy B, Mills GB. The biology of ovarian cancer: new opportunities for translation. Nat Rev Cancer 2009;9:415-28.
2. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144:646-74.
3. Polyak K, Weinberg RA. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 2009;9:265-73.
4. Rosanò L, Spinella F, Di Castro V, et al. Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cells. Cancer Res 2005;65:11649-57.
5. Rosanò L, Spinella F, Bagnato A. The importance of endothelin axis in initiation, progression, and therapy of ovarian cancer. Am J Physiol Regul Integr Comp Physiol 2010;299:R395-404.
6. Rosanò L, Cianfrocca R, Spinella F, et al. Acquisition of chemoresistance and emt phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cells. Clin Cancer Res 2011;17:2350-60.
7. Jin H, Yu Y, Zhang T, et al. Snail is critical for tumor growth and metastasis of ovarian carcinoma. Int J Cancer 2010;126:2102-11.
8. Hosono S, Kajiyama H, Terauchi M, et al. Expression of Twist increases the risk for recurrence and for poor survival in epithelial ovarian carcinoma patients. Br J Cancer 2007;96:314-320.
9. Kajiyama H, Shibata K, Terauchi M, et al. Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells. Int J Oncol 2007;31:277-83.
10. Wang X, Ling MT, Guan XY, et al. Identification of a novel function of Twist, a bHLH protein, in the development of acquired Taxol resistance in human cancer cells. Oncogene 2004;23:474-82.
11. Mani SA, Guo W, Liao MJ, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008;133:704-15.
12. Berry NB, Bapat SA. Ovarian cancer plasticity and epigenomics in the acquisition of a stem-like phenotype. J Ovarian Res 2008;1:8.
13. Ahmed N, Abubaker K, Findlay J, Quinn M. Epithelial mesenchymal transition and cancer stem cell-like phenotypes facilitate chemoresistance in recurrent ovarian cancer. Curr Cancer Drug Targets 2010;10:268-78.
14. Helleman J, Smid M, Jansen MP, van der Burg ME, Berns EM. Pathway analysis of gene lists associated with platinum-based chemotherapy resistance in ovarian cancer: the big picture. Gynecol Oncol 2010;117:170-6.